首页> 外文期刊>Investigative ophthalmology & visual science >Effect of immunization with the mannose-induced acanthamoeba protein and acanthamoeba plasminogen activator in mitigating acanthamoeba keratitis.
【24h】

Effect of immunization with the mannose-induced acanthamoeba protein and acanthamoeba plasminogen activator in mitigating acanthamoeba keratitis.

机译:甘露糖诱导的棘阿米巴蛋白和棘阿米巴纤溶酶原激活剂免疫在减轻棘阿米巴角膜炎中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: The mannose-induced cytopathic protein (MIP-133) and Acanthamoeba plasminogen activator (aPA) play key roles in the pathogenesis of Acanthamoeba keratitis by inducing a cytopathic effect on the corneal epithelial and stromal cells and by production of proteolytic enzymes that facilitate the invasion of trophozoites through the basement membrane. The goal of the present study was to gain insight into the pathogenicity of Acanthamoeba infection as well as to determine whether oral immunization with aPA and MIP-133 produce an additive protection against Acanthamoeba keratitis. METHODS: MIP-133 and aPA were isolated by chromatography. The purity of the concentrated MIP-133 and aPA was confirmed by SDS-PAGE and fibrinolytic activity, respectively. aPA activity of Acanthamoeba cultures was quantitated by radial diffusion in fibrin-agarose gel. The capacity of aPA and MIP-133 to induce cytolysis of corneal epithelial cells was tested in vitro. Chinese hamsters were orally immunized with four weekly doses of aPA or MIP-133 conjugated with cholera toxin. The animals were immunized before infection to determine the prophylactic effect of oral immunization. The therapeutic effect of oral immunization with aPA and MIP-133 was determined after corneal infection had been established. The animals were then infected via Acanthamoeba castellanii-laden contact lenses. RESULTS: aPA was characterized in pathogenic and nonpathogenic strains of Acanthamoeba spp. Oral immunization with MIP-133 before and after infection with Acanthamoeba significantly reduced the severity of corneal infection which includes infiltration and ulceration (P < 0.05) and shortened the duration of the disease. Immunization with aPA alone did not significantly affect the course of disease (P > 0.05). CONCLUSIONS: These data suggest that once trophozoites invade the cornea, MIP-133 production is necessary to initiate corneal disease and plays an important role in the subsequent steps of the pathogenic cascade of Acanthamoeba keratitis.
机译:目的:甘露糖诱导的细胞病变蛋白(MIP-133)和棘阿米巴纤溶酶原激活剂(aPA)在棘阿米巴角膜炎的发病机理中起关键作用,方法是对角膜上皮和基质细胞诱导细胞病变作用,并通过产生蛋白水解酶来促进滋养体通过基底膜侵入。本研究的目的是深入了解棘阿米巴感染的致病性,并确定口服aPA和MIP-133免疫能否产生针对棘阿米巴角膜炎的附加保护作用。方法:采用色谱法分离MIP-133和aPA。浓缩的MIP-133和aPA的纯度分别通过SDS-PAGE和纤溶活性确定。通过在纤维蛋白-琼脂糖凝胶中的径向扩散来定量棘阿米巴培养物的aPA活性。在体外测试了aPA和MIP-133诱导角膜上皮细胞的细胞溶解的能力。用四周剂量的霍乱毒素缀合的aPA或MIP-133口服免疫中国仓鼠。在感染前对动物进行免疫以确定口服免疫的预防作用。确定角膜感染后,确定用aPA和MIP-133进行口服免疫的治疗效果。然后,通过载满棘阿米巴castellanii的隐形眼镜感染动物。结果:aPA的特征是致病性和非致病性的棘阿米巴属菌种。棘阿米巴感染前后用MIP-133口服免疫可显着降低角膜感染的严重程度,包括浸润和溃疡(P <0.05),并缩短了疾病的持续时间。单独使用aPA免疫不会显着影响疾病进程(P> 0.05)。结论:这些数据表明,一旦滋养体侵入角膜,MIP-133的产生是引发角膜疾病的必要条件,并且在棘阿米巴角膜炎的致病级联反应的后续步骤中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号